You are here

Article Text

Article menu
Download PDFPDF
DTB commentary
Effect of dapagliflozin in patients with heart failure
  1. Teck K Khong1,
  2. Joshua Au Yeung2
  1. 1Clinical Pharmacology, St George's University of London, London, UK
  2. 2Clinical Pharmacology, St Thomas' Hospital, London, UK
  1. Correspondence to Dr Teck K Khong, Clinical Pharmacology, St George's University of London, London, UK; tkhong{at}sgul.ac.uk

Abstract

Commentary on: McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019;381:1995–2008.

Series Editor: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George’s, University of London, UK.

  • drug-related side effects and adverse reactions
  • healthcare quality
  • access
  • and evaluation

https://doi.org/10.1136/dtb.2021.000010

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).

    • Provenance and peer review Commissioned; internally peer reviewed.